Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Callitas Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
M Pharma Acquires Assets from 40J’s 12
M Pharma Acquires Orlistat Assets from Chelatexx 13
Partnerships 14
Callitas Health Enters into Partnership with NFI Consumer Healthcare 14
M Pharma to Form Joint Venture 15
Licensing Agreements 16
Callitas Health Recieves Intellectual Property from Ronald J. Thompson 16
M Pharma Enters into Licensing Agreement for Pediatric Orphan Drug 17
Equity Offering 18
M Pharma Raises USD0.03 Million in Private Placement of Units 18
M Pharma Raises USD0.7 Million in Private Placement of Units 19
M Pharma to Raise USD0.3 Million in Private Placement of Units 20
M Pharma Raises USD0.86 Million in Private Placement of Units 21
M Pharma Raises USD1 Million in Private Placement of Units 22
Acquisition 23
M Pharma Acquires ToConceive 23
M Pharma Plans to Acquire Pharma Company with an FDA Approved Women’s Health Product 24
M Pharma Acquires Trimtec Biomedical 25
M Pharma Acquires RX Global Capital for USD1.9 Million 26
Callitas Therapeutics Inc – Key Competitors 27
Callitas Therapeutics Inc – Key Employees 28
Callitas Therapeutics Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Corporate Communications 30
Jun 07, 2018: James Thompson Elevated to President and Chief Executive Officer of Callitas Health 30
Jan 03, 2018: Callitas Announces New Interim CEO 31
Jun 08, 2017: M Pharmaceutical Appoints New Chief Financial Officer 32
Mar 03, 2017: M Pharmaceutical Appoints Kim Whittemore of San Diego, California to Its Board of Directors 33
Feb 21, 2017: M Pharmaceutical Appoints Mr. William A. Rodgers Jr., of Milton, Georgia to Its Board of Directors 34
Feb 13, 2017: M Pharmaceutical Appoints Mr. Gary Thompson President & CEO 35
Product News 36
Sep 29, 2017: ToConceive launches new paraben-free formula to promote natural conception 36
07/14/2017: M Pharmaceutical Provides Update on Extrinsa 37
Jan 24, 2017: M Pharmaceutical Announces Strategy To Seek Distribution Partners For Their Patented Technologies To Deliver Phytoestrogens For The Treatment Of The Symptoms Of Menopause 38
Jan 12, 2017: M Pharmaceutical Announces Plans to Develop a Drug Product for Treatment of Female Sexual Dysfunction 39
Product Approvals 40
Oct 11, 2017: Callitas Announces Positive FDA Response to Extrinsa Pre-IND Submission 40
Jul 18, 2017: M Pharmaceutical Plans to Submit Extrinsa PIND Meeting Request Letter and Package to US FDA 41
Other Significant Developments 42
Apr 19, 2018: Callitas Health Releases Annual Update Letter to Shareholders 42
Mar 13, 2018: Callitas Health Announces Selection Of TraDigitalIR As Investor And Public Relations Advisor 44
Mar 01, 2018: Callitas Health Has Big Plans For Broad Product Portfolio 45
Sep 15, 2017: M Pharmaceutical Announces Name Change to Callitas Health and Share Consolidation 47
Aug 01, 2017: M Pharmaceutical USA Announces a Change of Name to Callitas Therapeutics 48
Jul 07, 2017: M pharmaceutical reforecasts 2017 and 2018 revenues upward 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Callitas Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Callitas Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
M Pharma Acquires Assets from 40J’s 12
M Pharma Acquires Orlistat Assets from Chelatexx 13
Callitas Health Enters into Partnership with NFI Consumer Healthcare 14
M Pharma to Form Joint Venture 15
Callitas Health Recieves Intellectual Property from Ronald J. Thompson 16
M Pharma Enters into Licensing Agreement for Pediatric Orphan Drug 17
M Pharma Raises USD0.03 Million in Private Placement of Units 18
M Pharma Raises USD0.7 Million in Private Placement of Units 19
M Pharma to Raise USD0.3 Million in Private Placement of Units 20
M Pharma Raises USD0.86 Million in Private Placement of Units 21
M Pharma Raises USD1 Million in Private Placement of Units 22
M Pharma Acquires ToConceive 23
M Pharma Plans to Acquire Pharma Company with an FDA Approved Women's Health Product 24
M Pharma Acquires Trimtec Biomedical 25
M Pharma Acquires RX Global Capital for USD1.9 Million 26
Callitas Therapeutics Inc, Key Competitors 27
Callitas Therapeutics Inc, Key Employees 28
Callitas Therapeutics Inc, Subsidiaries 29
List of Figures
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Callitas Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Callitas Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10